Penny Stocks To Consider – September 19th

IM Cannabis, Generation Income Properties, Lakeside, Recursion Pharmaceuticals, Uranium Royalty, TNL Mediagene, and TruGolf are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of very small or developing companies that trade at low prices, often below $5 per share, and may be listed on over-the-counter markets rather than major exchanges. They typically have low liquidity, limited public information, and high price volatility, making them riskier investments for stock market investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

IM Cannabis (IMCC)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.

Read Our Latest Research Report on IMCC

Generation Income Properties (GIPR)

Generation Income Properties, Inc., located in Tampa, Florida, is an internally managed real estate investment trust formed to acquire and own, directly and jointly, real estate investments focused on retail, office, and industrial net lease properties in densely populated submarkets.

Read Our Latest Research Report on GIPR

Lakeside (LSH)

Lakeside Holding Limited, through its subsidiaries, provides integrated cross-border supply chain solution in the United States, China, South Korea, and internationally. It offers a range of integrated services under cross-border ocean freight solutions and cross-border airfreight solutions, including cross-border freight consolidation and forwarding services, customs clearance services, warehousing and distribution services, and U.S.

Read Our Latest Research Report on LSH

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers.

Read Our Latest Research Report on RXRX

Uranium Royalty (UROY)

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.

Read Our Latest Research Report on UROY

TNL Mediagene (TNMG)

Read Our Latest Research Report on TNMG

TruGolf (TRUG)

Read Our Latest Research Report on TRUG

Recommended Stories